Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: Wink who wrote (2570)	1/30/1999 1:07:00 PM
From: Elio Madama	Respond to of 4650

Wink, you are welcome. I will keep posting Level II. ADOT holds approximately 23 percent of BioModa Inc. with an option to increase that position to 26.4. I got this info from the PR of Jan. 4th, 1999. I will post it later. Elio

To: Wink who wrote (2570)	1/30/1999 1:12:00 PM
From: Elio Madama	Read Replies (2) \| Respond to of 4650

***ANOTHER PRESS RELEASE FROM 1998*** ****MAINLY FOR NEW INVESTORS****** ====================================================================== R NEWSWIRE) DJ: Advanced Optics Electronics Initiates Buy-Back of Compan DJ: Advanced Optics Electronics Initiates Buy-Back of Company Shares; Company Also Reports Addition of Noted Scientific Consultant to Optics Division ALBUQUERQUE, N.M.--(BUSINESS WIRE)--June 11, 1998--Advanced Optics Electronics, Inc. today announced that management has begun a buy-back program of the Company's shares on the open market. Advanced Optics' management believes that the Company's shares are currently undervalued, and that a buy-back of shares at current market prices represents an opportunity for the Company to benefit itself and ADOT shareholders. Advanced Optics plans to retire all repurchased shares, thus bringing an increase in earnings and book value to the Company. The Company will continue its buy-back program for as long as management feels its shares are underpriced. Advanced Optics will regularly update its Web site, www.adot.org, with information pertinent to this buy-back program. Advanced Optics also announced that Dr. Garth Gobeli, a noted physics expert, has joined the Company as a full-time consultant in the area of optics-electronics. Dr. Gobeli will provide a wealth of experience in helping us further improve our state-of-the-art design and fabrication in the areas of illumination and imaging. Advanced Optics' goal is to stay at the forefront of optics electronics technology. Dr. Gobeli most recently worked as a senior scientist in the Physical Optics Group at Sandia National Laboratories and as research physicist at Bell Laboratories in Murray Hill, NJ. Advanced Optics Electronics, Inc. (OTC BB: ADOT - news) is a developer of patented electronic display technology, utilizing ADOT's proprietary SLM (Spatial Light Modulator) light valve. This industry-leading technology can be utilized in many diverse fields, including the production of "television-quality" advertising billboards, medical testing equipment, military displays, computer monitors and high-definition video transmission. Advanced Optics Electronics actively seeks partnerships with companies in fields that could benefit from ADOT's patented technology. ADOT also owns in excess of 27% of Biomoda, Inc., an emerging biotechnology company specializing in breakthrough cancer diagnostics and therapy. Advanced Optics Electronics, Inc. has retained first right of refusal to design, manufacture and distribute the necessary scanning testing devices for the lung cancer tests using Advanced Optics Electronics' proprietary display technology. This press release contains forward-looking statements with respect to the results of operations and business of the Company that involves risk and uncertainties. The Company's actual future results could materially differ from those discussed. Risks and uncertainties of the Company will be detailed from time to time in the Company's periodic reports to be filed with the Securities and Exchange Commission. CONTACT: Advanced Optics Electronics, Inc. 505/797-7878 Web Site: adot.org 11:32 EDT JUNE 11, 1998

To: Wink who wrote (2570)	1/30/1999 1:19:00 PM
From: Elio Madama	Respond to of 4650

************MORE NEWS 1998************ ====================================================================== PR NEWSWIRE) DJ: Advanced Optics Electronics Files 10-SB to Become Fully DJ: Advanced Optics Electronics Files 10-SB to Become Fully Reporting; Technology Partner, BioModa, Inc., Initiates Program to Market Lung Cancer Test to The People's Republic of China ALBUQUERQUE, N.M.--(BW HealthWire)--July 1, 1998--Advanced Optics Electronics, Inc. (OTC BB:ADOT) announced today they have filed Form 10-SB with the SEC to become a fully reporting company. Advanced Optics considers this SEC filing to be a significant step toward the Company's goal of a full NASDAQ listing. As a fully reporting company, Advanced Optics also becomes a more credible market candidate, capable of attracting investment analyst coverage, thus ensuring better market support both domestically and internationally. Advanced Optics also announced today that their technology partner, BioModa, Inc. has secured additional technology patents in Australia and with the Russian Federation, and has patents pending in 14 other countries. These patents further protect BioModa's proprietary early detection test for lung cancer and BioModa's proprietary lung cancer treatment program. BioModa, Inc., after two years of negotiations, has additionally embarked on a new program in cooperation with the Shanghai Center on New Drug Development in The People's Republic of China (PRC). BioModa will work with the Shanghai Center (owned jointly by the city of Shanghai and the Chinese Government) to provide Shanghai and the country of China with an economical turn-key medical package that will accurately diagnose various forms of lung cancer up to six years earlier than any test currently available. The objective of this program is to address an urgent need among the Chinese population. The PRC reports that over 900,000 Chinese people die each year from lung cancer. Although China has over 300 million smokers, a large number of lung cancer cases can be attributed to working in factories where caustic chemicals and noxious fumes are found. This press release contains forward-looking statements with respect to the results of operations and business of the Company that involves risk and uncertainties. The Company's actual future results could materially differ from those discussed. Risks and uncertainties of the Company are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. ABOUT ADVANCED OPTICS: Advanced Optics Electronics, Inc. (OTC BB:ADOT - news) is a developer of patented electronic display technology, utilizing ADOT's proprietary Spatial Light Modulator light valve. This industry-leading technology can be utilized in the production of "television quality" advertising billboards, medical testing equipment, military displays, computer monitors and high definition video transmission to name a few. Advanced Optics Electronics actively seeks partnerships with companies in fields that could benefit from ADOT's technology. ADOT also owns over 27% of BioModa, Inc., an emerging biotechnology company specializing in breakthrough cancer diagnostics and therapy. Advanced Optics can also design, manufacture and distribute the scanning devices for the lung cancer tests using Advanced Optics Electronics' proprietary display technology. CONTACT: Advanced Optics Electronics, Inc. 505/797-7878 adot.org 08:31 EDT JULY 1, 1998